« Back to Record
Citation APA

Drouillard, A., Puleo, F., Bachet, J.-B., Ouazzani, S., Calomme, A., Demetter, P., Verset, G., Van Laethem, J.-L., & Marechal, R. (2016). DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. British Journal of Cancer, 115(10), 1245-1252. doi:10.1038/bjc.2016.319


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/240344

Drouillard, A., Puleo, F., Bachet, J.-B., Ouazzani, S., Calomme, A., Demetter, P., Verset, G., Van Laethem, J.-L., & Marechal, R. (2016). DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. British Journal of Cancer, 115(10), 1245-1252. doi:10.1038/bjc.2016.319